Related Experiment Video

Updated: Oct 4, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Omega-3 fatty acids decrease protein kinase expression in human breast cancer cells

N G Moore1, F Wang-Johanning, P L Chang

  • 1Department of Nutrition Sciences, The University of Alabama at Birmingham, 35294-3360, USA.

Breast Cancer Research and Treatment
|September 20, 2001
PubMed

Insights

Omega-3 fatty acids, eicosapentaenoic and docosahexaenoic acids, significantly reduced key protein expressions in human breast cancer cells. This finding suggests potential therapeutic targets for breast cancer treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Protein kinase A (PKA) and protein kinase C (PKC) are crucial in cell signaling.
  • Aberrant PKA and PKC activity are implicated in human breast cancer progression.
  • Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are omega-3 fatty acids with known biological effects.

Purpose of the Study:

  • To investigate the effects of EPA and DHA on specific protein expressions in human breast cancer cells.
  • To determine if EPA and DHA modulate the expression of the RIalpha subunit of PKA and the PKC-alpha isozyme.

Main Methods:

  • Human breast cancer cell line MDA-MB-231 were exposed to physiological concentrations of EPA and DHA.
  • Exposure duration was 5 days.
  • Expression levels of RIalpha (PKA regulatory subunit) and PKC-alpha were measured.

Main Results:

  • A significant decrease in the expression of the RIalpha regulatory subunit of protein kinase A was observed.
  • A strong reduction in the expression of the PKC-alpha isozyme of protein kinase C was also noted.
  • These effects were observed after 5-day exposure to EPA and DHA.

Conclusions:

  • EPA and DHA significantly downregulate key signaling proteins in MDA-MB-231 breast cancer cells.
  • The observed decrease in RIalpha and PKC-alpha expression may have implications for breast cancer therapy.
  • Further research is warranted to explore the therapeutic potential of omega-3 fatty acids in breast cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...